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Reproducibility in the diagnosis of needle core biopsies of non-palpable breast lesions: an
international study using virtual slides published on the world-wide web
Aims: To conduct an internet-based study using virtual
slides (VS) of sterotactic core biopsy specimens of
non-palpable breast lesions in order to evaluate inter-
observer reproducibility between pathologists.
Methods and results: A total of 18 breast lesions,
determined to be histologically complex by two pathol-
ogists, were selected. Digitized VSs were then created
using QuickTime Virtual Reality technology (Apple,
Cupertino, CA, USA) and posted on the world-wide
web. In all, 10 pathologists completed the evaluations
of 18 VSs using the five diagnostic categories (B1–B5)
from the European guidelines for quality assurance in
breast cancer screening and diagnosis. Their results were
compared with those of every other participating
pathologist, and were then individually compared with
the results of a highly experienced breast pathologist
(referee). Of the 18 cases, 10 (56%) were classified by
the referee as borderline (B3 and B4). Comparisons
with reference values showed a less than satisfactory
level of reproducibility (median jw = 0.60). As regards
interobserver reproducibility, results showed that, in
general, the level of agreement was not satisfactory
(median jw = 0.53).
Conclusions: Overall, the findings are comparable to
those quality control studies using circulating slides
when analysis is done on borderline cases.
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Introduction
The use of new computer-based interactive technol-
ogies in medicine, such as virtual reality (VR), is
increasing. VR applications play an important role in
medical training because it is possible to learn in an
environment of absolute safety. This is obviously
important in the field of surgery and for other
invasive medical procedures. It is also important for
training in pathology because it makes access to a
large variety of digitized cytological and histological
(virtual slide) cases possible. Furthermore, virtual
slides (VSs) enable one to overcome several difficulties
related to pathology practice. For example, one
problem associated with the use of traditional glass
slides is that their distribution among pathologists
during quality assurance (QA) programmes is often
inefficient, requiring much time to complete conven-
tional quality control programmes. Furthermore,
there is the risk of significant differences between
samples cut from multiple tissue sections from the
same paraffin block. There have been very few quality
control studies that have verified the diagnostic
reproducibility of VS.1–14 The purpose of this study
was to assess whether pathologists are able to make
an accurate and reproducible diagnosis on-line using
VSs of selected core breast lesion biopsy specimens
with particular regard to borderline lesions. These
lesions are difficult to diagnose and published inte-
robserver reproducibility studies have shown a low
level of agreement among pathologists.15–19 In 1991,
Rosai18 highlighted this problematic aspect, but as yet
there has been no significant improvement in the
diagnosis of these lesions. These data suggest that
new and more feasible models of QA are necessary in
order to improve agreement in the diagnosis of
borderline lesions. To this end, the authors carried
out an on-line interobserver study of VSs generated
from stereotactic breast core biopsies specimens with
the goal of determining the interobserver agreement
between general pathologists and an expert in the
field of breast pathology.
Materials and methods
VSs were generated from 18 cases of large core needle
breast biopsy specimens of complex non-palpable
lesions originally evaluated at the Department of
Pathology, National Cancer Institute (Bari, Italy). The
chosen cases resulted from routine referrals to the
department, and were chosen for this study as a result
of their particular complexity, which required the
opinion and expertise of more than one pathologist.
Large areas of the haematoxylin and eosin-stained
slides were digitized to high power (20·) using a digital
camera (Olympus DP20, resolution: 1600 · 1200
pixel) mounted on a microscope (Olympus BX 41)
and connected to a computer in order to generate VSs
using QuickTime VR (Apple, Cupertino, CA, USA)
technology.20 A web-page was created (http://www.
oncologico.bari.it/istopatologia/index.html) to allow
access to the server that contained the VSs. The
participants were recruited via e-mail using a mailing
list of Italian pathologists (ITAPAT; http://www.
siapec.it) and by personal invitation via e-mail. At the
time of registration into the study, the pathologists
provided data regarding the institution to which they
belonged, and the number of cases of breast pathology
per year. For each VS, a reference diagnosis was
provided by an experienced breast pathologist (I.E.),
from the Department of Histopathology, University of
Nottingham, UK. The participating pathologists were
then required to classify the VSs according to the five
categories of the European guidelines for quality assurance
in breast cancer screening and diagnosis21: B1, normal
tissue ⁄ unsatisfactory; B2, benign lesion; B3, uncertain
malignant potential; B4, suspicious of malignancy; B5,
malignant. In addition, an open box was provided for a
written diagnostic description of each case for the
purpose of verifying the appropriateness of the diag-
nostic category. Interobserver reproducibility was
assessed, as well as the reproducibility between each
pathologist, and those of the referee, by computing the
weighed j statistic (jw).
22 The jw statistic is the most
widely accepted measure of agreement when, as in our
case, the data in question arise from an ordinal scale.
Its values usually lie between 0 (absence of agreement)
and 1 (absolute agreement). A negative value may be
obtained in situations where the actual agreement is
less than a chance one. In addition, we investigated the
contribution of each diagnostic category of observed
reproducibility by determining the j category-specific
statistics (jcs) and their weighted average (Cohen’s
j statistic, jc). Finally, we evaluated the interchange-
ability between any two different diagnostic categories
using the j interchangeability statistics (ji) computed
as suggested by Holman.23 As previously reported,24
jw values were considered satisfactory if equal to 0.80,
whereas values of jcs and jc were interpreted in a
qualitative manner on the basis of the Landis and
Koch25 classification criteria. Positive ji values indicate
a level of interchangeability between the two categories
under consideration which is greater than expected by
merely a chance effect. Conversely, negative values
have to be considered satisfactory, as they indicate
a good discriminatory capability between the two
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considered categories. Furthermore, in order to vali-
date the QuickTime VR technology, the reproducibility
between the reference VS diagnoses and the diagnoses
based on traditional histological slides made by two
experienced breast pathologists (F.A.Z. and G.S.) was
evaluated. The pathologists were given 6 months to
complete the diagnoses.
Results
A satisfactory level of reproducibility (jw = 0.83)
between the diagnoses made in a blind study of
traditional glass slides was carried out by two pathol-
ogists from the same institution, and the diagnoses
made from the corresponding VSs by the referee.
Table 1. Distribution of the diagnoses made from the referee and from the pathologists
Virtualslide (VS) Referee’s diagnoses
Pathologists’ diagnoses
B1–2 B3 B4 B5
VS-1 B5: Clear cell ductal carcinoma in situ 4 4 1 1
VS-2 B2: Sclerosing adenosis 10
VS-3 B3: Adenosis with epithelial atypia 8 2
VS-4 B3: Flat epithelial atypia with at least atypical ductal
hyperplasia
1 6 1 2
VS-5 B4: Flat epithelial atypia with at least atypical ductal
hyperplasia and features suspicious of ductal carcinoma
in situ
1 3 6
VS-6 B5: Invasive carcinoma with classical lobular features 10
VS-7 B5: Invasive carcinoma with tubular features 10
VS-8 B3: Unusual case with glandular structures involving
peripheral nerve-like structures. Could be invasive
carcinoma, benign hamartoma or adenosis involving
nerve
3 3 4
VS-9 B5: Invasive carcinoma with tubulolobular features.
Background flat epithelial atypia and probable
low-grade micropapillary ductal carcinoma in situ
3 2 5
VS-10 B5: Low-grade ductal carcinoma in situ with
background flat epithelial atypia
1 9
VS-11 B4: Flat epithelial atypia with features of at least atypical
ductal hyperplasia and areas suspicious of mucin
hypersecretory micropapillary ductal carcinoma in situ
1 5 4
VS-12 B3: Adenosis with epithelial atypia 3 6 1
VS-13 B3: Adenosis with epithelial atypia. May be part of a
fibroepithelial lesion or hamartoma
2 5 2 1
VS-14 B3: Adenosis with epithelial atypia. Probable lobular
neoplasia. Would look at E-cadherin and cytokeratin
expression
3 4 1 2
VS-15 B2: Focal lactational change 8 1 1
VS-16 B2: Sclerosing adenosis 7 1 2
VS-17 B3: Papillary lesion 5 1 4
VS-18 B3: Radial scar 4 5 1
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A total of 36 pathologists from various parts of the
world originally enrolled in the study; however, only
10 provided diagnoses for all of the 18 diagnostic cases
under consideration (Table 1).
Reproducibility analysis was performed by adopting
a classification criterion based on four categories
obtained by jointly considering B1 and B2 categories.
Lesions were classified by the referee as follows: three
cases B1 ⁄ B2; eight cases B3; two cases B4; five cases
B5.
The open box, which was inserted into the web
page, demonstrated a good level of appropriateness
between the descriptive diagnoses and the diagnostic
categories. In those diagnostic categories with a high
level of agreement, there was also a high level of
agreement in the descriptive diagnosis furnished in
the open box (e.g. in VS 2, 100% of pathologists
indicated the B2 category, and in the open box all of
the pathologists made a diagnosis of adenosis). Five of
the pathologists did not identify any lesions in the B4
category.
In four cases (VS-1, VS-3, VS-8 and VS-11) the
prevalent diagnostic category chosen by the patholo-
gists was different from that of the referee (Table 1).
Comparisons with reference diagnoses (Table 2)
showed a less than satisfactory level of reproducibility
with a median jw value of 0.60 (range 0.19–0.82) that
did not correlate with the numbers of cases per year of
each department (Table 3). For only one pathologist
was a jw value >0.80 observed.
Regarding interobserver reproducibility, results
showed that, in general, the level of agreement was
not satisfactory, with a median jw value of 0.53 (range
)0.18 to 1.00). Table 2 reports the distribution of jw
values observed for each pathologist compared with all
the others.
As shown in Table 4, the most significant contribu-
tion to overall agreement (jc = 0.30) was provided by
the two extreme diagnostic categories showing
fair ⁄ moderate agreement (B1 ⁄ B2, jcs = 0.40; B5,
jcs = 0.41). The least significant contribution was
found in the intermediate categories B3 (jcs = 0.15)
and B4 (jcs = )0.001), showing slight agreement and
Table 2. Reproducibility versus referee and interobserver
reproducibility – jw values
Pathologist’s
code
Reproducibility
versus referee
Interobserver reproducibility
Minimum Median Maximum
P01 0.42 )0.18 0.35 0.46
P02 0.67 0.28 0.51 0.79
P03 0.60 0.12 0.63 0.82
P04 0.60 0.18 0.51 0.72
P05 0.61 0.07 0.55 0.79
P06 0.19 )0.18 0.07 0.36
P07 0.56 0.07 0.53 1.00
P08 0.82 0.01 0.63 0.82
P09 0.62 0.19 0.63 0.74
P10 0.56 0.07 0.53 1.00
Overall 0.60 )0.18 0.53 1.00
Table 3. Number of breast samples per year compared with
the value of reproducibility versus referee (jw)
Pathologist’s
code
Breast stereotactic
biopsies (n)
Surgical breast
specimens (n) jw
P01 330 270 0.42
P02 120 100 0.67
P03 3000 800 0.60
P04 150 80 0.60
P05 1000 3500 0.61
P06 405 240 0.19
P07 200 380 0.56
P08 80 130 0.82
P09 300 400 0.62
P10 3000 800 0.56
Table 4. jcs and ji values
Category B1 + B2 B3 B4 B5
B1 + B2 0.40* )0.07† )0.01 )0.34
B3 )0.08 0.15 0.03 )0.13
B4 )0.09 0.21 )0.001 )0.13
B5 )0.26 )0.09 )0.01 0.41
*jcs values (in bold) measure the contribution of each
category to the overall agreement.
†ji values (in italic) measure the discriminatory capacity
between any two different categories.
Virtual reality in breast pathology 723
 2010 The Authors. Journal compilation  2010 Blackwell Publishing Ltd, Histopathology, 56, 720–726.
disagreement, respectively. Table 4 shows that positive
ji values were observed only for the B3 versus B4
pair (ji = 0.03) and for the B4 versus B3 pair
(ji = 0.21), indicating that the discriminatory
diagnostic capacity related to categories B3 and B4
was not satisfactory.
The mean time needed to complete the diagnoses
was 71.7 days (range 4–141 days) (Table 5). The way
in which the web page was set allowed us to know
whether the site was accessed one or more times by
each participant, but not the precise number of times.
Discussion
The detection of minimally invasive carcinoma, ductal
carcinoma in situ (DCIS) and borderline lesions of the
breast has increased dramatically since the introduc-
tion of mammographic screening. Notwithstanding the
fact that the histopathological diagnostic accuracy of
stereotactic core biopsy specimens is high for malignant
and benign lesions, it remains low for borderline
lesions. Studies carried out on circulating slides of core
biopsy specimens, surgical specimens, and even on
pre-sampled, still digital images have shown a low
level of agreement among pathologists for borderline
lesions.15–19,26
The results of this study on VSs seem to reproduce
the data of such studies on conventional circulating
slides of core biopsy specimens.15,19 Agreement among
pathologists is high in the two extreme categories of
benign and malignant lesions, respectively (B1 ⁄ B2 and
B5), and low in B3 and B4 lesions (Table 4).
The low discriminatory capacity to distinguish B3
from B4 categories (positive value of ji), and the
absence of any diagnoses in the B4 category by five
pathologists shows a use of the two categories which is
not clear-cut. The B4 category, which includes tech-
nical problems, does not allow for a definitive diagnosis
of a probable carcinoma, nor cases of intraductal
proliferation with extensive and severe atypia.27 This
latter condition was reported by the referee due to a
high degree of suspicion: ‘at least atypical ductal
hyperplasia (ADH), suspicious of low grade DCIS’
(VS-5 and VS-11). It is clear that this pragmatic
approach is subjective, resulting in a case being
categorized as either B3 or B4.
In our study, the prevalent diagnostic category
chosen by the pathologists was in concordance with
the referee in 14 cases. The other four cases were
discordant regarding the prevalent diagnoses, probably
for the following reasons: cases VS-1 (clear cell DCIS)
and VS-8 (indefinite neoplasia involving nerve) were
unusual and particular cases; in case VS-11 (flat
epithelial atypia with features of at least ADH and
areas suspicious of mucin hypersecretory micropapil-
lary intraductal carcinoma) none of the pathologists
chose B4, choosing instead either B3 or B5, probably
because of the contemporary presence of multiple
complex lesions; and in case VS-3 (adenosis with
atypia) there were no clear standardized diagnostic
criteria to evaluate lesions with benign architectural
features, but rather with cytological atypia. In this case
the diagnostic category chosen fluctuated between B2
and B3.
The absence of correlation between the number of
cases of breast pathology per year and jw values is a
confounding variable, which can probably be explained
by each of the participants’ technological abilities.
However, when the overall agreement on VSs is
considered, comparing these results with the data
reported in the literature on interobserver diagnostic
reproducibility on circulating slides, the use of VSs
would seem to determine a low level of agreement
among pathologists with respect to conventional stud-
ies. As a matter of fact, the two studies reported in the
literature15,19 on interobserver reproducibility on
breast core needle biopsy specimens have shown good
agreement among pathologists when all cases are
considered. However, when analysis is done exclusively
on borderline cases, the degree of agreement falls
dramatically. Verkooijen,19 in a multicentre study,
showed that the concordance between the general and
expert pathologists was only 24% for borderline cases.
Collins,15 in another multicentre study, showed lower
levels of agreement for ADH (63%). These two studies
have a low percentage of borderline cases (4–5%),
which explains the high level of agreement between
observers. The only single study conducted on-line in
which the diagnoses on VSs were compared with glass
slides has shown a concordance of 35.3% in the B3
category, even though it had only one case included in
the B3 category, and no cases of B4.7 Conversely, the
Table 5. Time taken for each pathologist to complete the diagnoses
Pathologist’s code P01 P02 P03 P04 P05 P06 P07 P08 P09 P10 Mean
Time taken (days) 51 82 78 141 43 42 4 98 103 75 71.7
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high percentage (56%) of B3 and B4 cases in our study,
most certainly influenced the results.
There was a high drop-out rate in this study, and it
was noted that the great majority of the original 36
participants accessed the web page only once without
making any diagnoses. This may have been due to
curiosity regarding the technology itself.
In conclusion, it would seem that our results are
similar to those QA studies in which circulating glass
slides were used. This could be a good starting point for
other QA rounds to improve the skill of pathologists in
the diagnosis of borderline lesions. Actually, VS tech-
nology has some advantages over circulating tradi-
tional glass slides: less time required to complete the
studies; easy distribution of cases without geographical
limitations; and easy repetition of the study once
transformed into a web format. Furthermore, on-line
reproducibility studies on VSs would not lose their
efficacy at the end of the study because they can
remain active in on-line document repositories that are
available on the internet in order to improve the skills
and knowledge of interested pathologists (http://onco-
logico.bari.it/istopatologia/index.html). Similar studies
could be useful permanent educational on-line
resources for the improvement of pathologists’ perfor-
mance.
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